Chemoradiotherapy for esophageal cancer: current status and perspectives

[1]  M. Orringer,et al.  Esophageal cancer: Clinical Practice Guidelines in oncology™ , 2006 .

[2]  Nils Lehmann,et al.  Chemoradiation with and without surgery in patients with locally advanced squamous cell carcinoma of the esophagus. , 2005, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[3]  Christopher U. Jones,et al.  Cetuximab prolongs survival in patients with locoregionally advanced squamous cell carcinoma of head and neck: A phase III study of high dose radiation therapy with or without cetuximab. , 2004, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[4]  H. Yamana,et al.  Surgery plus chemotherapy compared with surgery alone for localized squamous cell carcinoma of the thoracic esophagus: a Japan Clinical Oncology Group Study--JCOG9204. , 2003, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[5]  S. Yoshida,et al.  Nonrandomized comparison between definitive chemoradiotherapy and radical surgery in patients with T(2-3)N(any) M(0) squamous cell carcinoma of the esophagus. , 2003, International journal of radiation oncology, biology, physics.

[6]  Narikazu Boku,et al.  Long-term toxicity after definitive chemoradiotherapy for squamous cell carcinoma of the thoracic esophagus. , 2003, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[7]  S. Yoshida,et al.  EMR as salvage treatment for patients with locoregional failure of definitive chemoradiotherapy for esophageal cancer. , 2003, Gastrointestinal endoscopy.

[8]  L. Zuraw,et al.  Clinical investigation: esophagusCombined modality radiotherapy and chemotherapy in nonsurgical management of localized carcinoma of the esophagus: A practice guideline☆ , 2003 .

[9]  K. Kaneko,et al.  Definitive chemoradiotherapy for patients with malignant stricture due to T3 or T4 squamous cell carcinoma of the oesophagus , 2003, British Journal of Cancer.

[10]  Xiaomao Guo,et al.  Comparison between continuous accelerated hyperfractionated and late-course accelerated hyperfractionated radiotherapy for esophageal carcinoma. , 2002, International journal of radiation oncology, biology, physics.

[11]  D. Girling.  Surgical resection with or without preoperative chemotherapy in oesophageal cancer: a randomised controlled trial , 2002, The Lancet.

[12]  Y. Nishimura,et al.  Prospective trial of concurrent chemoradiotherapy with protracted infusion of 5-fluorouracil and cisplatin for T4 esophageal cancer with or without fistula. , 2002, International journal of radiation oncology, biology, physics.

[13]  Y. Nakanishi,et al.  Clinicopathologic characteristics and survival of patients with clinical Stage I squamous cell carcinomas of the thoracic esophagus treated with three-field lymph node dissection. , 2001, European journal of cardio-thoracic surgery : official journal of the European Association for Cardio-thoracic Surgery.

[14]  R. Glynne-Jones,et al.  Preoperative (neoadjuvant) chemoradiotherapy in oesophageal cancer , 2001, The British journal of surgery.

[15]  M. Iannettoni,et al.  Randomized trial of preoperative chemoradiation versus surgery alone in patients with locoregional esophageal carcinoma. , 2001, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[16]  Y. Kitagawa,et al.  Improvement in the Results of Surgical Treatment of Advanced Squamous Esophageal Carcinoma During 15 Consecutive Years , 2000, Annals of surgery.

[17]  A. Wong,et al.  Is combined chemotherapy and radiation therapy equally effective as surgical resection in localized esophageal carcinoma? , 1999, International journal of radiation oncology, biology, physics.

[18]  S. Yoshida,et al.  Definitive chemoradiotherapy for T4 and/or M1 lymph node squamous cell carcinoma of the esophagus. , 1999, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[19]  J. Cooper,et al.  Chemoradiotherapy of Locally Advanced Esophageal Cancer: Long-term Follow-up of a Prospective Randomized Trial (RTOG 85-01) , 1999 .

[20]  C. Falkson,et al.  A randomized study of radiotherapy alone versus radiotherapy plus 5-fluorouracil and platinum in patients with inoperable, locally advanced squamous cancer of the esophagus. , 1998, American journal of clinical oncology.

[21]  J. Kirkwood,et al.  Combined chemoradiotherapy vs. radiotherapy alone for early stage squamous cell carcinoma of the esophagus: a study of the Eastern Cooperative Oncology Group. , 1998, International journal of radiation oncology, biology, physics.

[22]  C. Willet,et al.  Patterns of care study decision tree and management guidelines for esophageal cancer. American College of Radiology. , 1998, Radiation medicine.

[23]  B. Jeremic,et al.  Accelerated hyperfractionated radiation therapy and concurrent 5-fluorouracil/cisplatin chemotherapy for locoregional squamous cell carcinoma of the thoracic esophagus: a phase II study. , 1998, International journal of radiation oncology, biology, physics.

[24]  N. Choi,et al.  Induction therapy for esophageal cancer with paclitaxel and hyperfractionated radiotherapy: a phase I and II study. , 1997, The Journal of thoracic and cardiovascular surgery.

[25]  J. Bosset,et al.  Chemoradiotherapy followed by surgery compared with surgery alone in squamous-cell cancer of the esophagus. , 1997, The New England journal of medicine.

[26]  M. Ducreux,et al.  Accelerated fractionation in esophageal cancers: a multivariate analysis on 88 patients. , 1997, International journal of radiation oncology, biology, physics.

[27]  J. Cooper,et al.  Progress report of combined chemoradiotherapy versus radiotherapy alone in patients with esophageal cancer: an intergroup study. , 1997, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[28]  T. Walsh,et al.  A comparison of multimodal therapy and surgery for esophageal adenocarcinoma. , 1996, The New England journal of medicine.

[29]  H. Sack,et al.  Combined preoperative chemotherapy and radiotherapy in patients with locally advanced esophageal cancer. Interim analysis of a phase II trial. , 1996, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[30]  Y. Kajiyama,et al.  Radical Lymph Node Dissection for Cancer of the Thoracic Esophagus , 1994, Annals of surgery.

[31]  S. Hoff,et al.  Preliminary results with neoadjuvant therapy and resection for esophageal carcinoma. , 1993, The Annals of thoracic surgery.

[32]  J. Cooper,et al.  Combined chemotherapy and radiotherapy compared with radiotherapy alone in patients with cancer of the esophagus. , 1992, The New England journal of medicine.

[33]  L. Souhami,et al.  A randomized trial comparing radiation therapy versus concomitant radiation therapy and chemotherapy in carcinoma of the thoracic esophagus , 1991, Cancer.

[34]  M. Stelzner,et al.  Surgical therapy of oesophageal carcinoma , 1990, The British journal of surgery.

[35]  H. Watanabe,et al.  Parameters linked to ten-year survival in Japan of resected esophageal carcinoma. Japanese Committee for Registration of Esophageal Carcinoma Cases. , 1989, Chest.

[36]  T. Daniel,et al.  Cisplatin, 5‐fluorouracil, mitomycin C, and concurrent radiation therapy with and without esophogectomy for esophageal carcinoma , 1989, Cancer.

[37]  Makiko Tanaka,et al.  Results of radiotherapy for inoperable locally advanced esophageal cancer. , 1989, International journal of radiation oncology, biology, physics.

[38]  D. Sun,et al.  Ten-year follow-up of esophageal cancer treated by radical radiation therapy: analysis of 869 patients. , 1989 .

[39]  Y. Tachimori,et al.  Definitive chemoradiotherapy may be standard treatment options in clinical stage I esophageal cancer. , 2004, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[40]  G. Giaccone,et al.  Gefitinib phase II study in second-line treatment of advanced esophageal cancer. , 2004, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[41]  S. Yoshida,et al.  Biopsy specimen microvessel density is a useful prognostic marker in patients with T(2-4)M(0) esophageal cancer treated with chemoradiotherapy. , 2002, Clinical cancer research : an official journal of the American Association for Cancer Research.

[42]  Ara A Vaporciyan,et al.  Salvage esophagectomy for recurrent tumors after definitive chemotherapy and radiotherapy. , 2002, The Journal of thoracic and cardiovascular surgery.

[43]  A. Szawłowski,et al.  p53 Protein accumulation as a prognostic marker of preoperative radiotherapy and/or chemotherapy in advanced squamous cell esophageal carcinoma--preliminary report. , 1999, Diseases of the esophagus : official journal of the International Society for Diseases of the Esophagus.

[44]  K. Hajiro,et al.  Neoadjuvant concurrent chemoradiotherapy followed by definitive high-dose radiotherapy or surgery for operable thoracic esophageal carcinoma. , 1998, International journal of radiation oncology, biology, physics.

[45]  G. Kerr,et al.  Results of radical radiotherapy of squamous cell carcinoma of the oesophagus. , 1982, Clinical radiology.